1. CTNI-04. TRAM-01: A PHASE 2 STUDY OF TRAMETINIB FOR PEDIATRIC PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 AND PLEXIFORM NEUROFIBROMAS. (14th November 2022) Authors: Kiaei, Dorsa Sadat; Larouche, Valerie; Décarie, Jean-Claude; Tabori, Uri; Hawkins, Cynthia; Lippe, Sarah; Ellezam, Benjamin; Ospina, Luis H; Theoret, Yves; Desjardins, Leandra; Metras, Marie-Elaine; Sultan, Serge; Cantin, Edith; Routhier, Marie-Eve; Mailloux, Chantal; Bertrand, Marie-claude; Caru... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CTNI-24. A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY. TRAM-01. (9th November 2020) Authors: Perreault, Sébastien; larouche, Valérie; Tabori, Uri; Hawkins, Cynthia; Lippe, Sarah; Ellezam, Benjamin; Décarie, Jean-Claude; Théoret, Yves; Metras, Marie-Élaine; Sultan, Serge; Cantin, Édith; Routhier, Marie-Ève; Caru, Maxime; Legault, Geneviève; Bouffet, Eric; Lafay-Cousin, Lucie; Hukin, Julie... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗